The biopharmaceutical landscape is undergoing a radical transformation as manufacturers shift away from traditional stainless-steel infrastructure toward more agile, cost-effective solutions. At the forefront of this evolution is the single-use bioreactor (SUB) market. According to a comprehensive study by Transpire Insight, the global single-use bioreactors market is projected to reach a...